Michael, M., Mulcahy, M. F., Deming, D. A., Vaghefi, H., Jameson, G. S., DeLuca, A., … Czito, B. G. (2015). Safety and tolerability of veliparib combined with capecitabine plus radiotherapy in patients with locally advanced rectal cancer (LARC): Final results of a phase Ib study. In Journal of Clinical Oncology (Vol. 33, pp. 3517–3517). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2015.33.15_suppl.3517

Michael, Michael, Mary Frances Mulcahy, Dustin A. Deming, Houman Vaghefi, Gayle S. Jameson, Angela DeLuca, Hao Xiong, et al. “Safety and tolerability of veliparib combined with capecitabine plus radiotherapy in patients with locally advanced rectal cancer (LARC): Final results of a phase Ib study.” In Journal of Clinical Oncology, 33:3517–3517. American Society of Clinical Oncology (ASCO), 2015. https://doi.org/10.1200/jco.2015.33.15_suppl.3517.

Michael M, Mulcahy MF, Deming DA, Vaghefi H, Jameson GS, DeLuca A, et al. Safety and tolerability of veliparib combined with capecitabine plus radiotherapy in patients with locally advanced rectal cancer (LARC): Final results of a phase Ib study. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015. p. 3517–3517.

Michael, Michael, et al. “Safety and tolerability of veliparib combined with capecitabine plus radiotherapy in patients with locally advanced rectal cancer (LARC): Final results of a phase Ib study.” Journal of Clinical Oncology, vol. 33, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2015, pp. 3517–3517. Crossref, doi:10.1200/jco.2015.33.15_suppl.3517.

Michael M, Mulcahy MF, Deming DA, Vaghefi H, Jameson GS, DeLuca A, Xiong H, Munasinghe W, Dudley MW, Komarnitsky P, Holen KD, Czito BG. Safety and tolerability of veliparib combined with capecitabine plus radiotherapy in patients with locally advanced rectal cancer (LARC): Final results of a phase Ib study. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015. p. 3517–3517.